[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to predict watchful waiting duration in patients with metastatic clear cell renal cell carcinoma

Verhoeff, S. R., Oosting, S. F., Elias, S. G., van Es, S. C., Gerritse, S. L., Angus, L., Heskamp, S., Desar, I. M. E., Menke-van der Houven van Oordt, C. W., van der Veldt, A. A. M., Arens, A. I. J., Brouwers, A. H., Eisses, B., Mulders, P. F. A., Hoekstra, O. S., Zwezerijnen, G. J. C., van der Graaf, W. T. A., Aarntzen, E. H. J. G., Oyen, W. J. G. & van Herpen, C. M. L., 1-Feb-2023, In: Clinical Cancer Research. 29, 3, p. 592–601 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting

Bos, M. K., Verhoeff, S. R., Oosting, S. F., Menke-van der Houven van Oordt, W. C., Boers, R. G., Boers, J. B., Gribnau, J., Martens, J. W. M., Sleijfer, S., van Herpen, C. M. L. & Wilting, S. M., 21-Feb-2023, In: Cancers. 15, 5, 11 p., 1374.

Research output: Contribution to journal › Article › Academic › peer-review

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

van der Veldt, A. A. M., Oosting, S. F., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A. M. C., Smit, E. F., Hiltermann, T. J. N., Hartog, G. D., Jalving, M., Westphal, T. T., Bhattacharya, A., de Wilt, F., Ernst, S. M., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., Rots, N. Y., & 3 othersvan Baarle, D., Haanen, J. B. A. G. & de Vries, E. G. E., Feb-2023, In: ESMO Open. 8, 1, 2 p., 100785.

Research output: Contribution to journal › Letter › Academic › peer-review

89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer

Verhoeff, S. R., van de Donk, P. P., Aarntzen, E. H. J. G., Oosting, S. F., Brouwers, A. H., Miedema, I. H. C., Voortman, J., Menke-van der Houven van Oordt, W. C., Boellaard, R., Vriens, D., Slingerland, M., Hermsen, R., van Engen-van Grunsven, I., Heskamp, S. & van Herpen, C. M. L., 1-Oct-2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 10, p. 1523-1530 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

A Randomized Ph2 Study of MEDI0680 in Combination With Durvalumab vs. Nivolumab Monotherapy in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Voss, M. H., Azad, A. A., Hansen, A. R., Gray, J. E., Welsh, S. J., Song, X., Kuziora, M., Meinecke, L., Blando, J., Achour, I., Wang, Y., Walcott, F. & Oosting, S. F., 15-Jul-2022, In: Clinical Cancer Research. 28, 14, p. 3032-3041 10 p.

Research output: Contribution to journal › Article › Academic › peer-review